PD-8 Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)
| Autor: | Moehler, M., Stein, A., Trojan, J., Marquardt, J., Quidde, J., Waidmann, O., Weinmann, A., Woerns, M., Schroeder, H., Mänz, M., Karatas, A. |
|---|---|
| Zdroj: | In Annals of Oncology July 2020 31 Supplement 3:S214-S214 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|